Medamicus Axia RSN
510(k) K020563
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK020563 | Date21 May 2002 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DYB
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1340
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 21 Sep 2026
The Medamicus Axia RSN is a medical device designed for embolization procedures. It consists of coils that are inserted into blood vessels to obstruct blood flow, effectively treating aneurysms or preventing hemorrhage.
It is intended to minimize needle stick injuries when used for percutaneous introduction of guidewires or similar devices. The device is supplied by Medamicus, Inc., has FDA 510(k) clearance under K020563, and is classified under product code DYB with a traditional clearance type and cardiovascular advisory committee review.
Other devices from Medamicus, Inc.
Questions
AI-generated answers, 21 Sep 2026
What is the Medamicus Axia RSN used for?
The Medamicus Axia RSN is designed for embolization procedures, where coils are inserted into blood vessels to obstruct blood flow. This helps treat aneurysms or prevent hemorrhage by blocking abnormal or dangerous blood flow in targeted vessels.
How is the Medamicus Axia RSN supplied and is it sterile?
The device is supplied by Medamicus, Inc. While the data does not explicitly state sterility, embolization coils are typically provided sterile for single-use in percutaneous procedures to prevent infection and ensure patient safety during vascular access.
What regulatory pathway was used for the Medamicus Axia RSN?
The Medamicus Axia RSN received FDA 510(k) clearance under submission number K020563, with a traditional clearance type and review by the cardiovascular advisory committee. It was found substantially equivalent to a predicate device, as indicated by the decision code SESE.